Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hopp

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
CNS Drugs|July 13, 2016
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label ExtensionWolfgang H Oertel, Yngve Hallström, Gerda M Saletu-Zyhlarz, et al.
Clinical Therapeutics|December 26, 2008
Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteersKevin Smith, Michael Hopp, Gill Mundin, et al.
Journal of Opioid Management|August 11, 2009
Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its managementPeter Holzer, Sam H Ahmedzai, Norbert Niederle, et al.
BMC Clinical Pharmacology|October 6, 2010
Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsOliver Löwenstein, Petra Leyendecker, Eberhard A Lux, et al.
European Journal of Pain (London, England)|September 3, 2008
A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipationWinfried Meissner, Petra Leyendecker, Stefan Mueller-Lissner, et al.
Expert Opinion on Investigational Drugs|March 15, 2011
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteersKevin Smith, Michael Hopp, Gill Mundin, et al.
Pharmacology|October 30, 2008
Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approachKaren Reimer, Michael Hopp, Michael Zenz, et al.
The Journal of Pain|August 19, 2008
Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic painDana Vondrackova, Petra Leyendecker, Winfried Meissner, et al.
Annals of Plastic Surgery|September 29, 2007
A liposome hydrogel with polyvinyl-pyrrolidone iodine in the local treatment of partial-thickness burn woundsHeinz-Herbert Homann, Oliver Rosbach, Wiebke Moll, et al.
Advances in Therapy|February 6, 2020
Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind TrialXiaomei Leng, Fengxiao Zhang, Shanglong Yao, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
CNS Drugs|July 13, 2016
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label ExtensionWolfgang H Oertel, Yngve Hallström, Gerda M Saletu-Zyhlarz, et al.
Clinical Therapeutics|December 26, 2008
Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteersKevin Smith, Michael Hopp, Gill Mundin, et al.
Journal of Opioid Management|August 11, 2009
Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its managementPeter Holzer, Sam H Ahmedzai, Norbert Niederle, et al.
BMC Clinical Pharmacology|October 6, 2010
Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsOliver Löwenstein, Petra Leyendecker, Eberhard A Lux, et al.
European Journal of Pain (London, England)|September 3, 2008
A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipationWinfried Meissner, Petra Leyendecker, Stefan Mueller-Lissner, et al.
Expert Opinion on Investigational Drugs|March 15, 2011
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteersKevin Smith, Michael Hopp, Gill Mundin, et al.
Pharmacology|October 30, 2008
Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approachKaren Reimer, Michael Hopp, Michael Zenz, et al.
The Journal of Pain|August 19, 2008
Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic painDana Vondrackova, Petra Leyendecker, Winfried Meissner, et al.
Annals of Plastic Surgery|September 29, 2007
A liposome hydrogel with polyvinyl-pyrrolidone iodine in the local treatment of partial-thickness burn woundsHeinz-Herbert Homann, Oliver Rosbach, Wiebke Moll, et al.
Advances in Therapy|February 6, 2020
Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind TrialXiaomei Leng, Fengxiao Zhang, Shanglong Yao, et al.
Pageof 3